Literature DB >> 1484411

[Effect of angiotensin II(AII) on peritoneal transport during peritoneal dialysis in rat].

M Go1, K Kumano, T Sakai.   

Abstract

Ultrafiltration volume (UFV) in peritoneal dialysis is expressed as the difference between net transcapillary ultrafiltration (TCUF) and lymphatic absorption (LA) in peritoneal cavity. An increase in LA results in a decrease in UFV. Endogenous hormones may modulate peritoneal membrane permeability and LA. This study was conducted to assess the effect of angiotensin II(AII) on peritoneal permeability and LA in rat. Rats (BW, approximately 300g) with normal renal function were dialyzed for 4 hours using 30ml of hypertonic dialysate (dextrose concentration: 3.86%). AII was added in dialysate at the concentration of 10(-9)-10(-2) mol/30ml. Peritoneal membrane permeability and UFV were studied by clearance of urea N and inorganic phosphate, albumin excretion, glucose absorption and LA. LA was calculated by the concentration change of dextran 70 in dialysate. AII decreased UFV from 15.7 +/- 2.8ml/4hr(control) to 5.7 +/- 1.5(AII 10(-4) mol/dwell). LA was increased in a dose dependent fashion (ED50:0.25 x 10(-6)mol) with no change in TCUF and clearances of urea N and inorganic phosphate. Ten types of AII analogue were used to investigate the site of action for LA in 8 amino acids of AII. [beta-Asp1], [Val5], [Ile3, Val5] and [Sar1] AII showed agonistic action against LA. [Sar1, Thr8], [Sar1, Ile8], [Sar1, Leu8], [Sar1, Ala8], [Sar1, Val5, Ala8] and [Sar1, Gly8] AII had no effect on LA, which found the importance of the 8th amino acid of AII for LA. These actions of AII analogue against LA were similar to those for vascular smooth muscle.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484411

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  1 in total

1.  The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients.

Authors:  Taner Basturk; Abdulkadir Unsal; Yener Koc; Eren Nezaket; Elbis Ahbap; Tamer Sakaci; Mustafa Sevinc
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.